Detail Information of Xenobiotics
General Information of Xenobiotics (ID: XEO00659) | ||||||
---|---|---|---|---|---|---|
Xenobiotics Name |
Exisulind
|
|||||
Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
Classification |
Drug in Phase 3 Clinical Trial
|
|||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5472495"></iframe>
|
|||||
3D MOL | 2D MOL | |||||
PubChem CID | ||||||
DME(s) Modulated by This Xenobiotics | ||||||
DME(s) Inhibited by This Xenobiotics | ||||||
Aldo-keto reductase 1B1 (AKR1B1) | DME Info | Homo sapiens | [1] | |||
Small intestine reductase (AKR1B10) | DME Info | Homo sapiens | [2] | |||
Phosphodiesterase 5A (PDE5A) | DME Info | Homo sapiens | [3], [4] | |||
DME(s) Induced by This Xenobiotics | ||||||
Adenosine 5'-monophosphoramidase (HINT1) | DME Info | Homo sapiens | [5] | |||
UDP-glucuronosyltransferase 1A1 (UGT1A1) | DME Info | Homo sapiens | [6], [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.